Success Stories: EB-1A Petition Approved within 15 days for a Georgia-based Research Associate (with PP, No RFE)

Client’s Testimonial:

“That’s a GREAT news! Thank you so much for all your help and guidance in this process. My case would not be so smooth without your assistance. I will definitely recommend your team to all my friends!”

On March 1^st, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Associate in the Field of Medical Research (Approval Notice).

General Field: Medical Research

Position at the Time of Case Filing: Research Associate

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Georgia

Approval Notice Date: March 1^st, 2017

Processing Time: 35 days (Premium Processing requested)

Case Summary:

When a research associate from China approached our firm—North America Immigration Law Group (WeGreened.com)— for help with his EB-1A (Alien of Extraordinary Ability) petition, we carefully assessed his credentials to evaluate his chances of petition approval. With a Ph.D. in Laboratory Medicine and an impressive record of contributions made to the field of medical research, he seemed like a good candidate for EB-1A. After confirming that our client had a solid case, we got to work detailing the various aspects of his professional portfolio:

Firstly, we highlighted the importance of his research and how it benefits the United States in the long run. His specialized research is focused on the molecular mechanisms that play a role in the pathogenesis of a myriad of diseases and health concerns including HIV/AIDS, cancer, kidney disease, hypertension, and birth defects. We also demonstrated that his efforts address the etiology and epidemiology of several life-threatening diseases and provide novel solutions which are of paramount importance to the United States, such as the development of strategies to curtail the transmission of HIV in at-risk populations.
Apart from our client’s contributions to the field of medical research, he also has an impressive record of accolades under his belt. At the time of filing, his research had garnered 125 citations and he had 26 peer-reviewed scientific articles and a book chapter to his name. Moreover, he had established himself as a scientist of important standing as evidenced in the 60 peer reviews he had conducted. These achievements undeniably positioned our client as a leader in the field of medical research.
Endorsing our client’s credentials were 6 letters of recommendation contributed by other experts in the field. According to one of the recommenders, a distinguished professor, our client “… is one such esteemed scientist who is clearly at the top of his field. His record of successes and uncommon scientific acumen ensure that he will remain an asset to molecular biology far into the foreseeable future.” Needless to say, these words of recommendation proved beyond a doubt that our client deserves to continue conducting his research in the United States.

Upgrading our client’s EB1A petition to Premium Processing (PP)* a little under a month after filing aided the expeditious approval of our client’s petition. Overall, he only waited 35 days for the USCIS to process and approve his case. The approval of our client’s I-140 is an encouraging sign of the effectiveness of our firm. We congratulate our client on his EB-1A petition approval and wish him all the best as he advances his field of medical research.

*PP is an option offered by the USCIS whereby the processing time is significantly reduced from 4-9 months and petitioners need not wait longer than 15 days for action to be taken on their cases.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.